<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0010">
 <label>2</label>
 <element-citation publication-type="journal" id="h0010">
  <person-group person-group-type="author">
   <name>
    <surname>Kandeel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Abdelrahman</surname>
    <given-names>A.H.M.</given-names>
   </name>
   <name>
    <surname>Oh-hashi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ibrahim</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Katharigatta</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease</article-title>
  <source>J. Biomol. Struct. Dyn.</source>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>8</lpage>
 </element-citation>
</ref>
